Company profile
CYPRUMED company profile
CYPRUMED® is a biopharmaceutical company developing a next generation platform technology for the oral delivery of polypeptides. The patent pending technology is entirely based on GRAS listed compounds and easy to formulate. In vivo studies with various polypeptide drugs in rodents, dogs and none human primates showed oral bioavailability up to 70% (rel. s.c.).
Business identity
- Website
- http://www.cyprumed.net/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Obsteig, Tyrol, Austria
- Postal code
- 6416
- Country code
- AT
- Continent
- Europe